Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 13, 2019

Total Value: $585M (100.0% shares, 0.0% debt)

Holdings (31)

LOXO ONCOLOGY INC 8.6%
Value $50.42M Shares 360,000 Est. Cost $28.44 Unrealized
MYOKARDIA INC 6.6%
Value $38.6M Shares 790,000 Est. Cost $30.98 Unrealized
BLUEPRINT MEDICINES CORP 5.9%
Value $34.5M Shares 640,000 Est. Cost $53.83 Unrealized
CDXS CODEXIS INC 5.8%
Value $33.82M Shares 2,025,000 Est. Cost $5.90 Unrealized +192.3%
SPARK THERAPEUTICS INC 5.6%
Value $32.88M Shares 840,000 Est. Cost $53.83 Unrealized
BLUEBIRD BIO INC 5.6%
Value $32.74M Shares 330,000 Est. Cost $124.02 Unrealized
FATE FATE THERAPEUTICS INC 5.6%
Value $32.72M Shares 2,550,000 Est. Cost $4.33 Unrealized +222.1%
SAGE THERAPEUTICS INC 5.1%
Value $29.89M Shares 312,000 Est. Cost $70.16 Unrealized
BLFS BIOLIFE SOLUTIONS INC 5.0%
Value $29.22M Shares 2,428,571 Est. Cost $15.38 Unrealized -22.4%
INVITAE CORP 4.5%
Value $26.54M Shares 2,400,000 Est. Cost $16.73 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.4%
Value $25.88M Shares 355,000 Est. Cost $83.48 Unrealized -7.9%
AGIO AGIOS PHARMACEUTICALS INC 3.5%
Value $20.52M Shares 445,000 Est. Cost $66.22 Unrealized -6.8%
GENMARK DIAGNOSTICS INC 3.2%
Value $18.54M Shares 3,815,000 Est. Cost $6.69 Unrealized
AUDENTES THERAPEUTICS INC 3.1%
Value $18.34M Shares 860,000 Est. Cost $23.89 Unrealized
ILMN ILLUMINA INC 3.1%
Value $18M Shares 60,000 Est. Cost $196.93 Unrealized +57.3%
SRPT SAREPTA THERAPEUTICS INC 2.8%
Value $16.37M Shares 150,000 Est. Cost $128.17 Unrealized -2.4%
MAGENTA THERAPEUTICS INC 2.6%
Value $15.07M Shares 2,643,317 Est. Cost $12.22 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 2.5%
Value $14.37M Shares 350,000 Est. Cost $32.45 Unrealized
SGMO SANGAMO THERAPEUTICS INC 2.1%
Value $12.4M Shares 1,080,000 Est. Cost $8.03 Unrealized +54.7%
GRITSTONE ONCOLOGY INC 1.9%
Value $11.13M Shares 720,586 Est. Cost $14.24 Unrealized
EVH EVOLENT HEALTH INC 1.9%
Value $10.97M Shares 550,000 Est. Cost $17.59 Unrealized +31.5%
EDIT EDITAS MEDICINE INC 1.9%
Value $10.92M Shares 480,000 Est. Cost $29.14 Unrealized -6.6%
VYGR VOYAGER THERAPEUTICS INC 1.8%
Value $10.6M Shares 1,128,075 Est. Cost $14.86 Unrealized
ONC BEIGENE LTD 1.7%
Value $9.818M Shares 70,000 Est. Cost $149.93 Unrealized
HOMOLOGY MEDICINES INC 1.3%
Value $7.826M Shares 350,000 Est. Cost $21.76 Unrealized
CONSTELLATION PHARMCETICLS I 1.1%
Value $6.244M Shares 1,556,998 Est. Cost $6.31 Unrealized
IBB ISHARES TR 1.0%
Value $5.786M Shares 60,000 Est. Cost $96.43 Unrealized
CDNA CAREDX INC 0.9%
Value $5.028M Shares 200,000 Est. Cost $11.47 Unrealized +124.1%
DNLI DENALI THERAPEUTICS INC 0.4%
Value $2.066M Shares 100,000 Est. Cost $18.14 Unrealized 0.0%
QUOTIENT LTD 0.3%
Value $1.989M Shares 325,000 Est. Cost $6.12 Unrealized
NEON THERAPEUTICS INC 0.2%
Value $1.325M Shares 263,344 Est. Cost $12.60 Unrealized